All PlansPrior AuthMedium impact
Prior Authorizations Eliminated for Substance Use Disorder Prescriptions
Healthfirst·NY · Psychiatry, Family Medicine, Internal Medicine +1 more·Provider Update
We identified it
Jun 20, 2026
Summary
Effective immediately, prior authorization is no longer required for substance use disorder medications including buprenorphine, methadone, long-acting injectable naltrexone, and opioid overdose reversal medications. This change applies to all insurers in New York State per recent budget legislation.
Action Required
Immediately: Billing team must update prior authorization requirements in billing system to remove PA requirements for all substance use disorder medications (buprenorphine products, methadone, long-acting injectable naltrexone, and opioid overdose reversal medications). Update encounter forms and staff training to reflect that these medications no longer require prior authorization for New York patients.